ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,299Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 337

$784K Total Retail Price of All Prescriptions

Rank: 22 out of 337

407 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 407 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 407 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,607 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
HYDROCODONE-ACETAMINOPHEN 603 225 S3 1 13
AMLODIPINE BESYLATE 532 368 2 3
LISINOPRIL 504 336 3 2
FUROSEMIDE 479 371 4 8
METOPROLOL TARTRATE 438 373 5 6
SIMVASTATIN 429 242 6 1
METFORMIN HCL 383 190 7 12
OMEPRAZOLE 360 146 8 4
RANITIDINE HCL 334 171 9 30
SERTRALINE HCL 270 201 10 18
LEVOTHYROXINE SODIUM 263 141 11 5
TRAZODONE HCL 251 197 12 16
NAMENDA 230 227 13 35
HYDROCHLOROTHIAZIDE 211 145 14 9
OXYCODONE HCL 210 64 S2 15 63
DONEPEZIL HCL 205 205 16 22
OXYCONTIN 201 42 S2 17 87
ZOLPIDEM TARTRATE 186 53 18 23
ATORVASTATIN CALCIUM 170 89 19 7
ATENOLOL 170 129 19 10
GABAPENTIN 152 73 21 20
LOSARTAN POTASSIUM 148 123 22 15
WARFARIN SODIUM 136 99 23 11
BISOPROLOL FUMARATE 125 36 24 67
IBUPROFEN 124 38 25 64
ALENDRONATE SODIUM 120 107 26 19
CITALOPRAM HBR 116 98 27 17
RISPERIDONE 112 45 28 72
ENALAPRIL MALEATE 104 100 29 37
GLYBURIDE 101 81 R 30 53
QUETIAPINE FUMARATE 101 62 30 61
PANTOPRAZOLE SODIUM 98 64 32 36
DOXAZOSIN MESYLATE 97 82 33 68
MIRTAZAPINE 95 86 34 27
TAMSULOSIN HCL 89 54 35 25
SYNTHROID 88 69 36 41
OXYCODONE HCL-ACETAMINOPHEN 86 20 S2 37 152
AZITHROMYCIN 85 48 38 51
LIPITOR 84 68 39 33
PROAIR HFA 83 42 40 38
PRAVASTATIN SODIUM 81 49 41 14
SPIRIVA 80 35 42 43
PAROXETINE HCL 79 68 43 46
VENLAFAXINE HCL ER 78 69 44 86
ISOSORBIDE MONONITRATE ER 76 67 45 70
DIOVAN 74 58 46 26
TRAMADOL HCL 74 47 46 32
ADVAIR DISKUS 70 24 48 44
MECLIZINE HCL 70 58 48 117
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 50 50 31
NEXIUM 69 0 50 56
ABILIFY 64 23 52 145
POLYETHYLENE GLYCOL 3350 64 20 52 47
KLOR-CON M20 63 50 54 65
METOPROLOL SUCCINATE 62 49 55 21
CLOPIDOGREL 62 58 55 42
GLIMEPIRIDE 61 46 57 55
ESCITALOPRAM OXALATE 61 19 57 66
LANTUS 60 18 59 49
FINASTERIDE 60 60 59 83
METFORMIN HCL ER 60 29 59 52
FAMOTIDINE 59 23 62 115
DIGOXIN 59 49 62 58
CRESTOR 59 42 62 29
EXELON 57 57 65 85
TERAZOSIN HCL 56 36 66 136
OXYCODONE-ACETAMINOPHEN 54 17 S2 67 84
FLUTICASONE PROPIONATE 54 20 67 34
PLAVIX 53 46 69 74
BETAMETHASONE VALERATE 53 12 69 258
VESICARE 53 30 69 257
COMBIVENT 52 19 72 126
INSULIN SYRINGE 51 35 73 127
NAPROXEN 51 14 73 98
BACLOFEN 51 11 73 133
ALLOPURINOL 50 35 76 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.